biotech company specialized on CO2 supercritical extraction of Cannabis, CBD and natural active substances
Canax has raised $1.4M in total funding. The most recent round was Debt Financing. The last funding was announced in March 2022.
Canax is headquartered in Milan, Italy.
biotech company specialized on CO2 supercritical extraction of Cannabis, CBD and natural active substances
Canax is at the Debt Financing stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Canax — Funding & Investors." VCBacked, March 16, 2022, https://www.vcbacked.co/company/canax. Accessed September 30, 2026.
VCBacked. (2022). Canax — Funding & Investors. Retrieved September 30, 2026, from https://www.vcbacked.co/company/canax
{{cite web |title=Canax — Funding & Investors |url=https://www.vcbacked.co/company/canax |website=VCBacked |access-date=September 30, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated